QR Pharma and UCLA Awarded $3 Million USARMY Grant to Test Posiphen® in Rat Models of Concussion and Blunt Head Trauma
Read more here
News
The Future of Drug Discovery: Two Required Supplements to Current Practices
Read more here
Relmada Therapeutics Inc. Completes $8.0 Million Capital Raise in Series A Financing
Read more here
Actelion Closes Acquisition of Privately-held Ceptaris Therapeutics Adding Valchlor to Actelion’s Product Portfolio
Read more here
TREVENTIS Corporation Closes $4.4 Million Financing with Wellcome Trust
Read more here
Relmada Therapeutics Inc. Announces Collaboration with the Malvern Consulting Group
Read more here
Jenrin Discovery Announces Recent Advances in Understanding of the Endocannabinoid System Using JD-5037
Read more here
Relmada Therapeutics Announces Positive Results of LevoCap ER Pivotal Pharmacokinetic Study
Read more here
Galderma Receives FDA Approval of Mirvaso®
Read more here
Ceptaris Receives FDA Approval for VALCHLOR(TM) (mechlorethamine) Gel
Read more here